Abstract
In September 2020, a detailed report on Heritable Human Genome Editing was published. The report offers a translational pathway for the limited approval of germline editing under limited circumstances and assuming various criteria have been met. In this perspective, some three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.
Original language | English |
---|---|
Pages (from-to) | 332-349 |
Number of pages | 18 |
Journal | CRISPR Journal |
Volume | 3 |
Issue number | 5 |
DOIs | |
Publication status | Published - Oct 2020 |